Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 1 (EIF1) is a universally conserved small protein essential for translation initiation in eukaryotic cells[1][2][4][5]. EIF1 binds to the 40S ribosomal subunit as part of the 43S preinitiation complex, cooperating with several other initiation factors to maintain the fidelity of start codon selection and to promote the scanning of mRNA[1][3]. It enables the ribosome to reject incorrect codon-anticodon pairings, thus ensuring accurate translation initiation at the start codon[1][3][5]. EIF1 interacts with the p110 subunit of the eukaryotic initiation factor 3 (eIF3), facilitating its recruitment to the ribosome[4][5]. It does not act as a typical drug target (such as an enzyme or receptor) and is not known to be directly involved in pathology or targeted by drugs, but is critical for proper cell function due to its central role in protein synthesis[1][3][4].\n\nNote: \nThe alias \"EIF1A\" refers to a related but distinct initiation factor (EIF1A); the above information is specific to \"EIF1\" (eIF1)[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 1 (EIF1).